Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1992)
Azithromycin . A review of its anti microbial , pharmacokinetic properties , and clinical efficacy
D. Parsad, R. Pandhi, R. Nagpal, K. Negi (2001)
Azithromycin Monthly Pulse vs Daily Doxycycline in the Treatment of Acne VulgarisThe Journal of Dermatology, 28
R. Skidmore, R. Kovach, C. Walker, John Thomas, M. Bradshaw, J. Leyden, C. Powala, R. Ashley (2003)
Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.Archives of dermatology, 139 4
D. Peters, H. Friedel, D. McTavish (1992)
Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.Drugs, 44 5
(1992)
A review of its anti microbial, pharmacokinetic properties, and clinical efficacy
(1998)
Disorders of the Sebaceous Glands in Textbook of Dermatology
F. Gruber, H. Grubišić-Greblo, M. Kaštelan, I. Brajac, M. Lenković, G. Zamolo (1998)
Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.Journal of chemotherapy, 10 6
S. Hopkins (1991)
Clinical toleration and safety of azithromycin.The American journal of medicine, 91 3A
(1981)
215-220 tion in acne vulgaris
D. Ferriman, J. Gallwey (1961)
Clinical assessment of body hair growth in women.The Journal of clinical endocrinology and metabolism, 21
(1983)
A doubleblind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris
S. Alvarez-Elcoro, M. Enzler (1999)
The macrolides: erythromycin, clarithromycin, and azithromycin.Mayo Clinic proceedings, 74 6
E. Eady, C. Jones, J Tipper, J. Cove, W. Cunliffe, A. Layton (1993)
Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.British Medical Journal, 306
A. Fernández-Obregón (2000)
Azithromycin for the treatment of acneInternational Journal of Dermatology, 39
D. Chalker, A. Shalita, J. Smith, R.W. Swann (1983)
A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris.Journal of the American Academy of Dermatology, 9 6
E. Eady, J. Cove, K. Holland, W. Cunliffe (1989)
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failureBritish Journal of Dermatology, 121
A. Layton (2001)
Optimal Management of Acne to Prevent Scarring and Psychological SequelaeAmerican Journal of Clinical Dermatology, 2
(2005)
The relationship between bacteria and the abnormal follicular keratiniza2005 Blackwell Publishing Ltd
M. Jacobs, S. Bajaksouzian, A. Windau, Caryn Good, Gengrong Lin, G. Pankuch, P. Appelbaum (2004)
Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study.Clinics in laboratory medicine, 24 2
Guy Webster (1995)
Inflammation in acne vulgaris.Journal of the American Academy of Dermatology, 33 2 Pt 1
E. Eady (1998)
Bacterial Resistance in AcneDermatology, 196
N. Scheinfeld, W. Tutrone, O. Torres, J. Weinberg (2004)
Macrolides in dermatology.Disease-a-month : DM, 50 7
P Pochi (1990)
The pathogenesis and treatment of acne.Annual review of medicine, 41
S. Garner, A. Eady, T. Avery (2002)
Robust evidence is needed in treating acneBMJ : British Medical Journal, 325
P. Bondavalli, A. Parodi, A. Rebora (1997)
Peripheral neuropathy in scleroderma successfully treated with amitriptylineInternational Journal of Dermatology, 36
R. Lavker, J. Leyden, K. McGinley (1981)
The relationship between bacteria and the abnormal follicular keratinization in acne vulgaris.The Journal of investigative dermatology, 77 3
S. Öncü, M. Punar, H. Eraksoy (2004)
Comparative Activities of β-Lactam Antibiotics and Quinolones for Invasive Streptococcus pneumoniae IsolatesChemotherapy, 50
J. Harper (2004)
An update on the pathogenesis and management of acne vulgaris.Journal of the American Academy of Dermatology, 51 1 Suppl
SummaryAcne vulgaris is a common inflammatory disorder of the skin. Oral antibiotics are known to be effective in its treatment. A randomized, investigator‐blinded study was performed to compare the efficacy of azithromycin with doxycycline. Fifty‐one patients were randomized to receive either azithromycin 500 mg/day on 3 consecutive days per week in the first, on 2 consecutive days per week in the second, and on 1 day per week in the third month. The other group was given doxycycline twice a day for the first month and once a day for the second and third months. Clinical assessment was made at baseline, at the end of first, second, third, and post‐treatment first and second months. Side effects were recorded. Statistically significant improvement for the facial lesions were obtained with both drugs. Neither drug was shown to be more effective than the other. The beneficial effect continued until 2 months after treatment. In the azithromycin group three patients had diarrohea, while photosensitivity was seen in two patients using doxycycline. This study indicates that azithromycin is at least as effective as doxycycline in the treatment of acne.
Clinical and Experimental Dermatology – Oxford University Press
Published: May 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.